Table 2:

Animal and human studies validating CTP

StudySubjectsValidation MethodResultsComments
Animal Studies
    Gobbel et al (1991)6925 Healthy dogsMicrospheresCBF: r = 0.95, P < .05
    Cenic et al (1999)6113 RabbitsMicrospheresCBF: r = 0.84, P < .001, slope = 0.97Deconvolution method
    Nabavi et al (1999)625 Healthy and 7 ischemic beaglesMicrospheresHealthy: CBF, r = 0.78, slope = 0.93; ischemic: r = 0.79, slope = 0.97Deconvolution method
    Cenic et al (2000)649 Rabbits with tumorsMicrospheres; postmortem histologyCBF: r = 0.85, P < .001, slope = 0.99Deconvolution method
    Nabavi et al (2001)667 Ischemic rabbitsCBF: r = 0.95, slope = 1.05Deconvolution method
CBV: r = 0.80, slope = 0.49
MTT: r = 0.85, slope = 0.95
Human studies
    Gillard et al (2000)722 With gliomas, 6 with AVMsPETr2 = 0.52Maximal slope method; VPE
    Wintermark et al (2001)679 With cerebrovascular diseaseXe-CTCBF: r2 = 0.79, slope = 0.87Deconvolution method
    Kudo et al (2003)705 Healthy subjectsPETCBF: r = 0.69, slope = 1.05Deconvolution method; VPE
    Sase et al (2005)717 Healthy subjectsXe-CTCBF: r2 = 0.46–0.93 depending on the brain region, P < .05, slopes <0.81 or >1.20Maximum slope method; VPE; different territories compared
    Kanazawa et al (2007)2928 Healthy subjectsXe-CTCBF: r = 0.61–0.70, P < .01Several territories compared
    Bisdas (2008)737 With strokesPETCBF: r = 0.77, P = .00Deconvolution method
  • Note:—AVM indicates arteriovenous malformation; PET, positron-emission tomography; Xe-CT, xenon-enhanced CT; VPE, vascular pixel elimination; CBF, cerebral blood flow; MTT, mean transit time.